Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Which Low Fee Index Funds Offer Best Value 2024 compares low-cost funds to help you pick the best value for retirement goals.
27,292 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A recent CFO Form 4 shows a small share disposition at Synaptics while the company reports 10% revenue growth. This a...
OpenAI is nearing a private funding round that could push its valuation above $850 billion, a level that would outstr...
G-III Apparel faced a sharp slide after its latest earnings, signaling investor caution about licensing-heavy fashion...
Investors eyeing SPRY's Q1 2026 results should understand how to parse a pharma earnings transcript. This guide break...
Cypherpunk Technologies reaffirms a 5% ZEC reserve despite a patched Zcash flaw, as investors debate the strategy ami...
A widow spent $1.1 million on cruise-ship art in the years after her husband’s death, shining a light on grief-driven...
Opendoor stock popped today amid optimism about profitability progress and better unit economics. This article breaks...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...
Pershing Square signals a bold bet by leaning into Microsoft as the AI and cloud wave reshapes enterprise tech. The m...
Abridge secures NVIDIA and Eli Lilly support to push an ambient AI platform toward a full hospital operating system. ...
A large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...